The safe usage of TILDREN has not been evaluated in horses less than four several years of age. The impact of bisphosphonates on the skeleton of rising horses has not been studied; on the other hand, bisphosphonates inhibit osteoclast action which impacts bone turnover and may have an impact on bone progress. A single horse which was administere